DGX:NYSE
Quest Diagnostics Inc
$228.34
arrow_downward
-0.02%(-0.050) 1D
Oct 7, 11:38:17 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DGX...
Open
$228.51
High
$229.80
Low
$226.98
Mkt. cap
25.20B
Avg. vol.
1.10M
Volume
252.87K
Dividend
1.51%
Quarterly dividend
$0.86
Ex-dividend date
Oct 6, 2026
P/E ratio
24.27
52-wk high
$248.84
52-wk low
$171.18
EPS
$9.41
Beta
0.54
Shares outstanding
110.37M
No. of employees
52K
Open
$228.51
High
$229.80
Low
$226.98
Mkt. cap
25.20B
Avg. vol.
1.10M
Volume
252.87K
Dividend
1.51%
Quarterly dividend
$0.86
Ex-dividend date
Oct 6, 2026
P/E ratio
24.27
52-wk high
$248.84
52-wk low
$171.18
EPS
$9.41
Beta
0.54
Shares outstanding
110.37M
No. of employees
52K
News stories
From web sources and news partners
TipRanks
·
18 hours ago
Quest Diagnostics announces executive transition and leadership continuity
News Corp
·
18 hours ago
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors
Profile
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing. Wikipedia
About Quest Diagnostics Inc
CEOJames E. Davis
Employees51.5K
Founded1967
Headquarters-
SectorHealth care provider
Websitequestdiagnostics.com